Natural Help For IBS
IM HealthScience,® announced the availability of IBgard,® a new natural health product for IBS — a condition that affects more than five million Canadians. The first of its kind in Canada, non-prescription IBgard® uses an innovative targeted technology to deliver peppermint oil directly to the small intestine, where IBS sufferers need it most.
“With more than 120,000 Canadians developing IBS each year, this is a therapeutic area that requires more treatment options,” said Dr. Albert Cohen, a Gastroenterologist at Sir Mortimer B. Davis-Jewish General Hospital. “IBgard® presents my current and future patients with more treatment options to combat the distressing symptoms that IBS sufferers live with, such as severe abdominal pain, bloating, diarrhea and constipation.”
IBgard® capsules contain individually triple-coated, sustained-release, microspheres of Ultramen,® an ultra-purified peppermint oil. Peppermint oil and its principal component l-Menthol, has a history of effectiveness in IBS. However, until now, its targeted delivery to the lower gut has posed a challenge. Only IBgard® utilizes the breakthrough science of SST® (Site Specific Targeting) technology, to deliver microspheres of peppermint oil (in a solid state) to the lower gut.
“We are excited and proud to be launching IBgard® in Canada as there exists a high unmet medical need for more options for people suffering from this condition,” indicated Stéphane Langevin General Manager Canada. “IBgard® is effective and well tolerated; in its first year of availability in the U.S., it quickly became the # 1 peppermint oil recommended for IBS by U.S. astroenterologists,” added Mr. Langevin.
IBgard® is entering the Canadian market at a time when the annual economic and national healthcare burden of IBS is in excess of $6.5 billion, not including over-the-counter drugs and prescriptions. Current acute care inpatient costs for IBS are ranked as Canada’s fourth most-expensive digestive disease. In addition, a patient with unmanaged IBS misses an average of 13 work days a year, resulting in an indirect cost of $8 billion in productivity loss a year.
IBgard® is now available in the digestive aisle in pharmacies nationwide.
For more information, visit www.IBgard.ca or to learn more about the company, visit www.imhealthscience.com.